|

A CCafU-UroCCR Randomized Trial: 3D Image-Guided Robot-AssisTEd Partial Nephrectomy for Renal Complex Tumor (UroCCR N°99)

RECRUITINGN/ASponsored by University Hospital, Grenoble
Actively Recruiting
PhaseN/A
SponsorUniversity Hospital, Grenoble
Started2023-01-24
Est. completion2023-01-24
Eligibility
Age18 Years+
Healthy vol.Accepted

Summary

The goal of this clinical trial is to evaluate peri and post-operative outcomes as well as long-term survival of 3D IGRAPN compared to conventional Robot-Assisted Partial Nephrectomy (RAPN) for moderate and highly complex renal tumors. The main questions aim to answer: * peri-operative complications * oncological safety * long term renal function Participants will be asked to do undergo 3D-IGRAPN. Researchers will compare 3D-IGRAPN to RAPN to see if peri-operative outcomes are better in the experimental group.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Patients over 18 years
* Indication of RAPN for suspicious renal tumor
* Moderate or high complexity renal tumor (RENAL Nephrometry Score (NS) \>7)
* Da Vinci® surgical system available for the surgery
* Patient affiliated to the French social security system or an equivalent system
* Signed informed consent form UroCCR and ACCURATE

Exclusion Criteria:

* Medical contraindication to RAPN
* Renal insufficiency forbidding iodine injection
* Patient with allergy to iodinated contrast products
* Patient concerned by articles L1121-5 to 8 of the French public health code (protected persons)

Conditions3

CancerRenal CancerRenal Tumor

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.